Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Oct;39(10):2171–2175. doi: 10.1128/aac.39.10.2171

Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

M M París 1, O Ramilo 1, G H McCracken Jr 1
PMCID: PMC162908  PMID: 8619561

Full Text

The Full Text of this article is available as a PDF (175.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahronheim G. A., Reich B., Marks M. I. Penicillin-insensitive pneumococci. Case report and review. Am J Dis Child. 1979 Feb;133(2):187–191. doi: 10.1001/archpedi.1979.02130020079017. [DOI] [PubMed] [Google Scholar]
  2. Alonso J., Madrigal V., García-Fuentes M. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr Infect Dis J. 1991 Mar;10(3):256–256. doi: 10.1097/00006454-199103000-00022. [DOI] [PubMed] [Google Scholar]
  3. Appelbaum P. C., Bhamjee A., Scragg J. N., Hallett A. F., Bowen A. J., Cooper R. C. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet. 1977 Nov 12;2(8046):995–997. doi: 10.1016/s0140-6736(77)92892-6. [DOI] [PubMed] [Google Scholar]
  4. Asensi F., Otero M. C., Pérez-Tamarit D., Rodríguez-Escribano I., Cabedo J. L., Gresa S., Cantón E. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus. J Chemother. 1993 Apr;5(2):133–134. doi: 10.1080/1120009x.1993.11739221. [DOI] [PubMed] [Google Scholar]
  5. Asensi F., Pérez-Tamarit D., Otero M. C., Gallego M., Llanes S., Abadia C., Cantó E. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus. Pediatr Infect Dis J. 1989 Dec;8(12):895–895. doi: 10.1097/00006454-198912000-00019. [DOI] [PubMed] [Google Scholar]
  6. Bradley J. S., Connor J. D. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 1991 Nov;10(11):871–873. [PubMed] [Google Scholar]
  7. Breiman R. F., Butler J. C., Tenover F. C., Elliott J. A., Facklam R. R. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994 Jun 15;271(23):1831–1835. [PubMed] [Google Scholar]
  8. Caputo G. M., Sattler F. R., Jacobs M. R., Appelbaum P. C. Penicillin-resistant pneumococcus and meningitis. Ann Intern Med. 1983 Mar;98(3):416–417. doi: 10.7326/0003-4819-98-3-416_2. [DOI] [PubMed] [Google Scholar]
  9. Catalán M. J., Fernández J. M., Vazquez A., Varela de Seijas E., Suárez A., Bernaldo de Quirós J. C. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis. 1994 May;18(5):766–769. doi: 10.1093/clinids/18.5.766. [DOI] [PubMed] [Google Scholar]
  10. Collignon P. J., Bell J., Hufton I. W., Mitchell D. Meningitis caused by a penicillin- and chloramphenicol-resistant Streptococcus pneumoniae. Med J Aust. 1988 Nov 7;149(9):497–498. doi: 10.5694/j.1326-5377.1988.tb120739.x. [DOI] [PubMed] [Google Scholar]
  11. Devitt L., Riley I., Hansman D. Human infection caused by penicillin-insensitive pneumococci. Med J Aust. 1977 Apr 16;1(16):586–588. doi: 10.5694/j.1326-5377.1977.tb130925.x. [DOI] [PubMed] [Google Scholar]
  12. Doit C. P., Bonacorsi S. P., Fremaux A. J., Sissia G., Cohen R., Geslin P. L., Bingen E. H. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Antimicrob Agents Chemother. 1994 Nov;38(11):2655–2659. doi: 10.1128/aac.38.11.2655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Eliopoulos G. M., Klimm K., Eliopoulos C. T., Ferraro M. J., Moellering R. C., Jr In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria. Antimicrob Agents Chemother. 1993 Feb;37(2):366–370. doi: 10.1128/aac.37.2.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Friedland I. R., Klugman K. P. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child. 1992 Aug;146(8):920–923. doi: 10.1001/archpedi.1992.02160200042023. [DOI] [PubMed] [Google Scholar]
  15. Friedland I. R., Klugman K. P. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 1992 Feb 15;339(8790):405–408. doi: 10.1016/0140-6736(92)90087-j. [DOI] [PubMed] [Google Scholar]
  16. Friedland I. R., Klugman K. P. Recurrent penicillin-resistant pneumococcal meningitis after chloramphenicol therapy. Pediatr Infect Dis J. 1991 Sep;10(9):705–707. doi: 10.1097/00006454-199109000-00018. [DOI] [PubMed] [Google Scholar]
  17. Friedland I. R., Paris M., Ehrett S., Hickey S., Olsen K., McCracken G. H., Jr Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1993 Aug;37(8):1630–1636. doi: 10.1128/aac.37.8.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Friedland I. R., Paris M., Shelton S., McCracken G. H. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J Antimicrob Chemother. 1994 Aug;34(2):231–237. doi: 10.1093/jac/34.2.231. [DOI] [PubMed] [Google Scholar]
  19. Friedland I. R., Shelton S., Paris M., Rinderknecht S., Ehrett S., Krisher K., McCracken G. H., Jr Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1993 Mar;12(3):196–200. doi: 10.1097/00006454-199303000-00004. [DOI] [PubMed] [Google Scholar]
  20. Gartner J. C., Michaels R. H. Meningitis from a pneumococcus moderately resistant to penicillin. JAMA. 1979 Apr 20;241(16):1707–1709. [PubMed] [Google Scholar]
  21. Girgis N. I., Farid Z., Mikhail I. A., Farrag I., Sultan Y., Kilpatrick M. E. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989 Dec;8(12):848–851. doi: 10.1097/00006454-198912000-00004. [DOI] [PubMed] [Google Scholar]
  22. Howes V. J., Mitchell R. G. Meningitis due to relatively penicillin-resistant pneumococcus. Br Med J. 1976 Apr 24;1(6016):996–996. doi: 10.1136/bmj.1.6016.996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Iyer P. V., Kahler J. H., Jacobs N. M. Penicillin-resistant pneumococcal meningitis. Pediatrics. 1978 Jan;61(1):157–158. [PubMed] [Google Scholar]
  24. Jackson M. A., Shelton S., Nelson J. D., McCracken G. H., Jr Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis. 1984 Mar-Apr;3(2):129–132. doi: 10.1097/00006454-198403000-00010. [DOI] [PubMed] [Google Scholar]
  25. John C. C. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994 Feb;18(2):188–193. doi: 10.1093/clinids/18.2.188. [DOI] [PubMed] [Google Scholar]
  26. Jorgensen J. H., Ferraro M. J., McElmeel M. L., Spargo J., Swenson J. M., Tenover F. C. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test. J Clin Microbiol. 1994 Jan;32(1):159–163. doi: 10.1128/jcm.32.1.159-163.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kadurugamuwa J. L., Hengstler B., Zak O. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis. 1989 Jan;159(1):26–34. doi: 10.1093/infdis/159.1.26. [DOI] [PubMed] [Google Scholar]
  28. Kanra G. Y., Ozen H., Seçmeer G., Ceyhan M., Ecevit Z., Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J. 1995 Jun;14(6):490–494. doi: 10.1097/00006454-199506000-00005. [DOI] [PubMed] [Google Scholar]
  29. Kennedy W. A., Hoyt M. J., McCracken G. H., Jr The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child. 1991 Dec;145(12):1374–1378. doi: 10.1001/archpedi.1991.02160120042016. [DOI] [PubMed] [Google Scholar]
  30. Kleiman M. D., Weinberg G. A., Reynolds J. K., Allen S. D. Meningitis with beta-lactam-resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr Infect Dis J. 1993 Sep;12(9):782–784. doi: 10.1097/00006454-199309000-00019. [DOI] [PubMed] [Google Scholar]
  31. Klugman K. P., Friedland I. R., Bradley J. S. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother. 1995 Sep;39(9):1988–1992. doi: 10.1128/aac.39.9.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Krisher K. K., Linscott A. Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae. J Clin Microbiol. 1994 Sep;32(9):2242–2245. doi: 10.1128/jcm.32.9.2242-2245.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lebel M. H., Freij B. J., Syrogiannopoulos G. A., Chrane D. F., Hoyt M. J., Stewart S. M., Kennard B. D., Olsen K. D., McCracken G. H., Jr Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med. 1988 Oct 13;319(15):964–971. doi: 10.1056/NEJM198810133191502. [DOI] [PubMed] [Google Scholar]
  34. Lebel M. H., Hoyt M. J., Waagner D. C., Rollins N. K., Finitzo T., McCracken G. H., Jr Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child. 1989 Mar;143(3):301–306. doi: 10.1001/archpedi.1989.02150150055017. [DOI] [PubMed] [Google Scholar]
  35. Leggiadro R. J., Barrett F. F., Chesney P. J., Davis Y., Tenover F. C. Invasive pneumococci with high level penicillin and cephalosporin resistance at a mid-south children's hospital. Pediatr Infect Dis J. 1994 Apr;13(4):320–322. [PubMed] [Google Scholar]
  36. Mace J. W., Janik D. S., Sauer R. L., Quilligan J. J., Jr Penicillin-resistant pneumococcal meningitis in an immunocompromised infant. J Pediatr. 1977 Sep;91(3):506–507. doi: 10.1016/s0022-3476(77)81339-5. [DOI] [PubMed] [Google Scholar]
  37. Marton A., Gulyas M., Munoz R., Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis. 1991 Mar;163(3):542–548. doi: 10.1093/infdis/163.3.542. [DOI] [PubMed] [Google Scholar]
  38. McCracken G. H., Jr, Nelson J. D., Kaplan S. L., Overturf G. D., Rodriguez W. J., Steele R. W. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J. 1987 Jun;6(6):501–505. [PubMed] [Google Scholar]
  39. McGee S. M., Kaplan S. L., Mason E. O., Jr Ventricular fluid concentrations of vancomycin in children after intravenous and intraventricular administration. Pediatr Infect Dis J. 1990 Feb;9(2):138–139. doi: 10.1097/00006454-199002000-00014. [DOI] [PubMed] [Google Scholar]
  40. Naraqi S., Kirkpatrick G. P., Kabins S. Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. J Pediatr. 1974 Nov;85(5):671–673. doi: 10.1016/s0022-3476(74)80513-5. [DOI] [PubMed] [Google Scholar]
  41. Nau R., Kaye K., Sachdeva M., Sande E. R., Täuber M. G. Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother. 1994 May;38(5):1186–1189. doi: 10.1128/aac.38.5.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Odio C. M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., Sáez-Llorens X., Olsen K. D., McCracken G. H., Jr The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991 May 30;324(22):1525–1531. doi: 10.1056/NEJM199105303242201. [DOI] [PubMed] [Google Scholar]
  43. Paredes A., Taber L. H., Yow M. D., Clark D., Nathan W. Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics. 1976 Sep;58(3):378–381. [PubMed] [Google Scholar]
  44. París M. M., Hickey S. M., Trujillo M., Shelton S., McCracken G. H., Jr Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1995 Jun;39(6):1243–1246. doi: 10.1128/aac.39.6.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. París M. M., Hickey S. M., Uscher M. I., Shelton S., Olsen K. D., McCracken G. H., Jr Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1994 Jun;38(6):1320–1324. doi: 10.1128/aac.38.6.1320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Ridgway E. J., Allen K. D., Neal T. J., Lombard M., Rigby A. Penicillin-resistant pneumococcal meningitis. Lancet. 1992 Apr 11;339(8798):931–931. [PubMed] [Google Scholar]
  47. Schaad U. B., Lips U., Gnehm H. E., Blumberg A., Heinzer I., Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet. 1993 Aug 21;342(8869):457–461. doi: 10.1016/0140-6736(93)91592-a. [DOI] [PubMed] [Google Scholar]
  48. Scheld W. M., Brodeur J. P. Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis. Antimicrob Agents Chemother. 1983 Jan;23(1):108–112. doi: 10.1128/aac.23.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sloas M. M., Barrett F. F., Chesney P. J., English B. K., Hill B. C., Tenover F. C., Leggiadro R. J. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992 Aug;11(8):662–666. [PubMed] [Google Scholar]
  50. Spangler S. K., Jacobs M. R., Appelbaum P. C. Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother. 1994 Apr;38(4):898–900. doi: 10.1128/aac.38.4.898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Tan T. Q., Schutze G. E., Mason E. O., Jr, Kaplan S. L. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994 May;38(5):918–923. doi: 10.1128/aac.38.5.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Täuber M. G., Khayam-Bashi H., Sande M. A. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis. 1985 Mar;151(3):528–534. doi: 10.1093/infdis/151.3.528. [DOI] [PubMed] [Google Scholar]
  53. Viladrich P. F., Gudiol F., Liñares J., Pallarés R., Sabaté I., Rufí G., Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991 Dec;35(12):2467–2472. doi: 10.1128/aac.35.12.2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Viladrich P. F., Gudiol F., Liñares J., Rufi G., Ariza J., Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med. 1988 May;84(5):839–846. doi: 10.1016/0002-9343(88)90061-7. [DOI] [PubMed] [Google Scholar]
  55. Weingarten R. D., Markiewicz Z., Gilbert D. N. Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults. Rev Infect Dis. 1990 Jan-Feb;12(1):118–124. doi: 10.1093/clinids/12.1.118. [DOI] [PubMed] [Google Scholar]
  56. Willett L. D., Dillon H. C., Jr, Gray B. M. Penicillin-intermediate pneumococci in a children's hospital. Am J Dis Child. 1985 Oct;139(10):1054–1057. doi: 10.1001/archpedi.1985.02140120100037. [DOI] [PubMed] [Google Scholar]
  57. Wong V. K., Wright H. T., Jr, Ross L. A., Mason W. H., Inderlied C. B., Kim K. S. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J. 1991 Feb;10(2):122–125. doi: 10.1097/00006454-199102000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES